Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | -0.60% | -2.37% | -23.08% |
Financials (USD)
Sales 2024 * | 62.7M | Sales 2025 * | 71M | Capitalization | 15.62M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -9M | EV / Sales 2024 * | 0.25 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.22 x |
P/E ratio 2024 * |
-0.76
x | P/E ratio 2025 * |
-1.59
x | Employees | 380 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.35% |
Latest transcript on Trinity Biotech plc
1 day | -0.60% | ||
1 week | -2.37% | ||
1 month | -5.71% | ||
3 months | -23.26% | ||
6 months | -35.29% | ||
Current year | -23.08% |
Managers | Title | Age | Since |
---|---|---|---|
John Gillard
CEO | Chief Executive Officer | 43 | 20-11-16 |
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Eibhlin Kelly
CTO | Chief Tech/Sci/R&D Officer | 40 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronan O'Caoimh
FOU | Founder | 68 | 92-05-31 |
Jim Walsh
BRD | Director/Board Member | 65 | 95-09-30 |
Thomas Lindsay
BRD | Director/Board Member | 66 | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.65 | -0.60% | 42,519 |
24-05-30 | 1.66 | +2.47% | 33,989 |
24-05-29 | 1.62 | -0.61% | 1,089 |
24-05-28 | 1.63 | -3.55% | 9,921 |
24-05-24 | 1.69 | +3.68% | 5,881 |
Delayed Quote Nasdaq, May 31, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.08% | 15.62M | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B |
- Stock Market
- Equities
- TRIB Stock